Company Humasis Co. Ltd.

Equities

A205470

KR7205470008

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Korea S.E. Other stock markets 03:30:00 26/04/2024 am IST			5-day change	1st Jan Change
1,770 ^KRW	+0.11%		+0.63%	-6.15%

18/03	Humasis Co. Ltd. announces an Equity Buyback for 17,533,607 shares.	CI
18/03	Humasis Co. Ltd. authorizes a Buyback Plan.	CI

Humasis Co Ltd is a Korea-based company principally engaged in the manufacture and sale of in vitro diagnostic devices. The Company is engaged in the manufacture and sale of immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, cancer marker test devices and other products. In addition, the Company is engaged in the research and development of biomaterials and other products. The Company sells its products within domestic market and to overseas markets. The Company was established in 2000 and is located in Gunpo-si, Gyeonggi-do, South Korea.

Number of employees: 175

KRW in Million	2022	Weight	2023	Weight	Delta
Diagnostic Reagents and Diagnostic Devices Product 94.1 %	463,816	99.2 %	12,858	94.1 %	-97.23%
Other 3.3 %	3,584	0.8 %	447	3.3 %	-87.54%
Diagnostic Reagents and Diagnostic Devices Merchandise 2.7 %	105	0.0 %	364	2.7 %	+245.07%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 67.7 %	218,656	46.8 %	9,253	67.7 %	-95.77%
Overseas 32.3 %	248,850	53.2 %	4,415	32.3 %	-98.23%

Managers	Title	Age	Since
Chung-Hak Cha CEO	Chief Executive Officer	59	28/17/28
Seung-Cheol Yoo BRD	Director/Board Member	60	-

Members of the board	Title	Age	Since
Seung-Cheol Yoo BRD	Director/Board Member	60	-
Chung-Hak Cha CEO	Chief Executive Officer	59	28/17/28
Seung-Woo Yoo BRD	Director/Board Member	56	28/17/28
Kang-Moon Lee BRD	Director/Board Member	59	01/15/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	129,375,009	109,903,276 ( 84.95 %)	2,162,077 ( 1.671 %)	84.95 %

Name	Equities	%	Valuation
Artist Co., Ltd. (Korea) 8.020 %	10,375,256	8.020 %	16 M ₩
Hee-chul Koo 4.902 %	6,341,828	4.902 %	10 M ₩
Insco Co. Ltd. 4.213 %	5,450,556	4.213 %	8 M ₩
HUMASIS CO. LTD. 1.671 %	2,162,077	1.671 %	3 M ₩
Jung-jin Lee 0.9427 %	1,219,644	0.9427 %	2 M ₩
INCON CO.,LTD. 0.6345 %	820,928	0.6345 %	1 M ₩
Gyeon Namgoong 0.5124 %	662,916	0.5124 %	1 M ₩
Byung-woo Cho 0.2587 %	334,708	0.2587 %	509 677 ₩
State Street Global Advisors Ltd. 0.0485 %	62,799	0.0485 %	95 627 ₩
Dimensional Fund Advisors Ltd. 0.0117 %	15,125	0.0117 %	23 032 ₩

Name	Equities	%	Valuation
HUMASIS CO. LTD. 1.67%	2,162,077	1.67%	3,292,303 $

HUMASIS Co., Ltd.

#504, Shinwon Vision Tower 88 Jeonpa-ro

14042, Anyang

http://www.humasis.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
HUMASIS CO. LTD.	-6.15%	164M
BIOMÉRIEUX	+0.89%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.61B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.49B
10X GENOMICS, INC.	-50.70%	3.3B
ANDON HEALTH CO., LTD.	+12.21%	2.73B
VITROLIFE AB	-16.13%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B
MYRIAD GENETICS, INC.	-5.02%	1.64B

Diagnostic & Testing Substances